Inhibition of Lipin lipid phosphatase hyperactivity rescues TorsinA neurological disease
TOR1A/TorsinA mutations cause poorly explained neurological diseases. A dominantly inherited mutation causes isolated dystonia, while biallelic mutations cause a recessive infant-onset syndrome with cases of lethality. Here we report an unexpected connection between lipid metabolism and these diseases. Lipin phosphatidic acid phosphatase activity was abnormally regulated in TorsinA dystonia patient cells, and in the brains of three different TorsinA disease model mice. Lipin activity was causative to symptoms given that lowering Lipin1 in vivo strongly intervened against lethality in disease mice. Furthermore, Lipin hyperactivity caused cell death in vitro, and Lipin1 deficiency suppressed neurodegeneration in vivo. In addition, it protected the striatal cholinergic interneurons that are implicated in TorsinA movement disorders, and concomitantly suppressed abnormal motor behaviors of TorsinA mice. These data establish the central role of Lipin lipid enzyme hyperactivity in TorsinA disease and show that Lipin inhibition is a therapeutic target for these incurable conditions.\n\nOne Sentence SummaryLipin inhibition rescues TorsinA neurological disease